Aptima™ HIV-1 Quant Dx Assay
High sensitivity and excellent precision for Human Immunodeficiency Virus 1 (HIV-1) viral load monitoring.1
Reliable Quantitation1
Deliver reliable, repeatable results with a robust dual-target assay that accurately detects and monitors HIV-1. Running the Aptima HIV-1 Quant DX assay on the Panther® System combines assay performance and excellent automation for viral load monitoring--a combination that delivers sample-to-result within a single integrated instrument.1
High Accuracy & Precision
The Aptima HIV Quant Dx assay is highly accurate for HIV-1 across the dynamic range of the assay.1-2
Efficient Workflow & Flexible Processing
No need for aliquoting or manual sample transfer. PPT, ACD and EDTA tubes are all validated.1 You can run multiple tests from a single sample. No manual sample preparation with primary tube loading to maintain positive sample identification.
Random Access & Rapid Turnaround Time
No more batching. You can run different test orders from the same sample as they arrive at the laboratory. Rapid turnaround time with first results in just 2 hours, 41 minutes. Prioritises STAT results.3
Automated Analysis & Dilution Factor
Automated QC analysis with Levey-Jennings plots to track and trend controls. Low sample volume option (240 μL) with automated dilution factor. Enables application of an automatic dilution factor instead of manual calculations.3
Simplify & Scale the Future of Diagnostics
The Aptima HIV-1 Quant Dx Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single-patient result to population-level screening.
Excellent Sensitivity & High Precision
High assay precision provides confidence that any detected increases in viral load are due to clinical changes in patients, rather than assay variation.1,4
12 copies/mL
Limit of detection (LoD)*
30 copies/mL
Lower limit of quantitation (LLoQ)
30-10 million copies/mL
Linear range*
Demand More from Your HIV-1 Assay1
- Intended use: diagnosis of primary HIV-1 infection, confirmation of HIV-1 infection, HIV-1 viral load monitoring
- Technology: Real-time Transcription-mediated Amplification (TMA)
- Target region: pol/LTR
- Groups: M, N, O
- Sample Types: serum and plasma (qualitative), plasma (quantitative)
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Insights
*Established using the 1st WHO International Standard.
- Aptima HIV-1 Quant Dx Assay [package insert] AW-11853-001. Rev.010 San Diego, CA; Hologic, Inc., 2021.
- Hopkins M, Hau S, Tiernan C, et.al. Comparative Performance of the New Aptima HIV-1 Quant Dx Assay With Three Commercial PCR-Based HIV-1 RNA Quantitation Assays. J Clin Virol. 2015;69:56-62.
- Panther / Panther Fusion Operators Manual. AW-26055-001 Rev. 001
- Nair SV, Kim HC, Fortunko J, et al. Aptima HIV-1 Quant Dx—a fully automated assay for both diagnosis and quantification of HIV-1. J Clin Virol. 2016;77:46-54.
Documents
Safety Data Sheets
Package Inserts
1434
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable